CERo Therapeutics Holdings (CERo Therapeutics Holdings) Preferred Dividends : $0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. CERo Therapeutics Holdings's preferred dividends for the six months ended in Dec. 2022 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

CERo Therapeutics Holdings Preferred Dividends Historical Data

The historical data trend for CERo Therapeutics Holdings's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Preferred Dividends Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

Preferred Dividends

CERo Therapeutics Holdings Semi-Annual Data
	Dec21	Dec22
Preferred Dividends	-	-

CERo Therapeutics Holdings Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

CERo Therapeutics Holdings (NAS:CERO) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024